CGHS Pharmacy Cadre Reform 2026: Group ‘B’ Status Granted, but 11-Year Promotion Rule Sparks Outcry

The Ministry of Health and Family Welfare has officially ushered in a new era for the Central Government Health Scheme (CGHS) by notifying the Recruitment Rules (RRs) for Senior Pharmacists (Allopathic). While the move elevates the profession to the Group ‘B’ Officer cadre for the first time in history, a controversial “11-year service” clause has triggered widespread dissent across the pharmacy community.

The Landmark Shift: Group ‘B’ Entry

For decades, CGHS pharmacists remained within the Group ‘C’ classification. The January 2026 gazette notification changes this structural landscape:

Official Title: Senior Pharmacist (Allopathic).
Classification: General Central Service, Group ‘B’, Non-Gazetted, Non-Ministerial.
Pay Structure: Placed in Pay Level-7 ($Rs. 44,900 – 1,42,400$) of the Central Pay Matrix.
Sanctioned Posts: A total of 270 positions have been approved, distributed across key hubs including Delhi, Ahmedabad, Bengaluru, Chennai, Chandigarh, Bhubaneswar, and Guwahati.

New Recruitment & Eligibility Protocols

The government has mandated that these positions be filled 100% through promotion, with deputation as a secondary fallback. To qualify, a candidate must:

Hold Rank: Currently be a Pharmacist (Allopathic) in Pay Level-5.
Experience: Complete 11 years of regular service in the current grade.
Training: Undergo a mandatory two-week specialized training program focused on administration, establishment, and accounts.
Probation: Serve a two-year probation period upon promotion.

The “11-Year” Controversy: Why Pharmacists are Protesting

The celebration of the new Group ‘B’ status has been overshadowed by a sharp deviation from the original draft. Mr. Ramraj Choudhary, representing CGHS Delhi pharmacists, along with various national associations, has formally raised objections.

“The extension from a proposed 5-year residency to 11 years is not just a delay; it is professional stagnation. It ignores the norms of comparable central services,” stated a representative body.

Key Grievances:

Deviation from Draft: The 2023 draft rules recommended a 5-year residency period. The sudden jump to 11 years in the final notification is being called “unjustified and discriminatory.”
Career Stagnation: Many pharmacists argue that this lengthy requirement will lead to a bottleneck, preventing qualified professionals from reaching senior administrative roles before retirement.
Call for Action: Associations are demanding an immediate amendment to reinstate the 5-year criteria, warning of collective action and potential legal challenges if the policy is not revised.

Summary Table: Draft vs. Final Notification

Feature	Draft Proposal	Final Notification (Jan 2026)
Residency Period	5 Years	11 Years
Pay Level	Level-7	Level-7
Status	Group ‘B’	Group ‘B’
Mandatory Training	Required	Required (2 Weeks)